Innovation driven company

Developing novel medical solutions

Pharmiva is an innovation driven company focused on providing solutions to common medical problems related to women’s health.

From the basis of our expertise in research and development of medical products for local treatment, we develop and market patented medical products.

We’re committed to finding solutions against the increasing global threat of antimicrobial resistance to antibiotics.

Solid experience in

Local Delivery Systems

Lund-based Pharmiva, founded in 2015, is a spinout from Zelmic, an experienced contract research organisation focused on development of pharmaceutical formulations.

Over the years, Zelmic has developed numerous topical, oral, intracavital and parenteral formulations, most of which have been subject to patent applications.

Today, Pharmiva is set up on developing and commercializing new innovations from a patented technology platform. Pharmiva’s research program is focusing on finding novel solutions to common medical problems in women’s health.

Next step, moving into

Commercialization

Based on the technology platform Venerol®, Pharmiva’s first product is a medical device against bacterial vaginosis.

Not yet available on the market, this OTC (over-the counter) product, offers a novel medical solution to non-antibiotic treatment of intimate infections in women.

The Venerol® technology platform is an excellent base for stabilization and delivery of a range of compounds that otherwise would have been degraded or not suited for local treatment, lending itself to further possibilities to grow the product portfolio, beyond the segment of intimate infections in women.

Highly Dedicated

We specialize in local treatments and delivery technology, developing and marketing new innovative medical solutions in women’s health.